Abstract
This study demonstrates that age- and sex-nondefined populations can be used for definition of reference values for glutamic acid decarboxylase (GAD65) antibodies and that comorbidity involving tissues that express GAD needs not be taken into account when screening for GAD antibodies. Because storage conditions may significantly affect the outcome of GAD antibody tests, these need to be monitored meticulously in collaborative studies.
| Original language | English |
|---|---|
| Pages (from-to) | 2269-2272 |
| Number of pages | 4 |
| Journal | Clinical Chemistry |
| Volume | 45 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 1999 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research programs
- EMC MM-01-54-01
Fingerprint
Dive into the research topics of 'Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and treshold values'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver